FDA News
🇺🇸 FDA Page 24FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 277–288 of 391 articles
AstraZeneca Secures FDA Approval for Hypertension Drug
FDA Approves Atezolizumab for Muscle-Invasive Bladder Cancer
Enhertu's Dual FDA Approvals: A Game Changer in Early Breast Cancer Treatment
Implications of CDER Leadership Changes at the FDA
Understanding the FDA: A Response to Marty Makary's Critique
FDA Leadership Changes Crisis: Implications for Drug Approvals
Leadership Changes at CDER and CBER: Implications for Oncology
Regulatory Round-Up: Key FDA Approvals for Cancer Drugs
FDA Shake-Up: Implications for Oncology and Beyond
FDA Approves AstraZeneca's Innovative Hypertension Drug
Supreme Court Ruling on Mifepristone: Implications for Pharma
Post-Hoc Live: Makary's Departure from FDA and Future Implications